期刊文献+

不同分期胃癌患者Survivin和Caspase-3表达差异分析

Analysis of Survivin and Caspase-3 Expression in Gastric Cancer Patients with Different Stages
下载PDF
导出
摘要 目的分析不同分期胃癌患者Survivin和Caspase-3蛋白表达的差异。方法2019年12月-2020年12月,以72例胃癌患者为研究对象。将Ⅰ期和Ⅱ期胃癌患者纳入早期组,将Ⅲ期和Ⅳ期胃癌患者纳入晚期组。采用免疫组织化学法,检测胃癌组织和正常组织的Survivin和Caspase-3的表达。结果在胃癌组织标本与正常组织标本比较方面,胃癌组织标本Survivin阳性率63.89%,正常组织Survivin阳性率为0.00%,胃癌组织标本Survivin阳性率高于正常组织。胃癌组织标本Caspase-3阳性率为38.89%,正常组织Caspase-3阳性率为85.00%,胃癌组织标本Caspase-3阳性率低于正常组织。在不同分期胃癌组织标本中,早期组Survivin阳性率为45.16%,晚期组Survivin阳性率为78.05%,晚期组Survivin阳性率高于早期组。早期组Caspase-3阳性率为61.29%,晚期组Caspase-3阳性率为21.95%,晚期组Caspase-3阳性率低于早期组,差异有统计学意义(P<0.05)。结论Survivin和Caspase-3蛋白表达,可在一定程度上作为判定胃癌患者病情发展的依据。 Objective To analyze the expression of Survivin and caspase-3 protein in patients with gastric cancer of different stages.Methods From December 2019 to December 2020,72 patients with gastric cancer were selected as subjects.Patients with stageⅠandⅡgastric cancer were included in the early group,and patients with stageⅢandⅣgastric cancer were included in the advanced group.The expressions of Survivin and caspase-3 in gastric cancer and normal tissues were detected by immunohistochemistry.Results The Survivin positive rate of gastric cancer tissue was 63.89%and 0.00%,respectively,higher than that of normal tissue.The positive rate of Caspase-3 was 38.89%in gastric cancer and 85.00%in normal tissues.The positive rate of Caspase-3 in gastric cancer was lower than that in normal tissues.In different stages of gastric cancer,the Survivin positive rate was 45.16%in the early group and 78.05%in the late group,which was higher than that in the early group.The positive rate of caspase-3 was 61.29%in the early group and 21.95%in the late group.The positive rate of caspase-3 was lower in the late group than in the early group.The difference was statistically significant(P<0.05).Conclusion The expression of Survivin and caspase-3 protein can be used as a basis to determine the progression of gastric cancer.
作者 朴海超 王春艳 PU Haichao;WANG Chunyan(Endoscopic Diagnosis and Treatment Center,Jilin Central Hospital,Jilin,Jilin 132013)
出处 《智慧健康》 2022年第7期65-67,共3页 Smart Healthcare
基金 吉林市医疗卫生指导性计划项目,“胃癌中Survivin、Caspase-3的表达及其相关性研究”(项目编号:2019001007)。
关键词 胃癌 SURVIVIN CASPASE-3 早期诊断 Gastric cancer Survivin Caspase 3 Early diagnosis
  • 相关文献

参考文献13

二级参考文献134

  • 1王强,赵滢,张天彪,寇有为.survivin、PTEN在胃癌组织中的表达以及相关性[J].中国医科大学学报,2009,38(4):270-273. 被引量:10
  • 2冯振中,陈嘉薇,杨兆瑞,路光中,蔡兆根.PTEN、HIF-1α和NDRG1在子宫内膜样腺癌中的表达和相关性研究[J].上海交通大学学报(医学版),2011,31(2):203-207. 被引量:4
  • 3刘小敏,唐荣军,周秀田,彭娟,宋颖,梁晓秋.PIG11蛋白在人体正常组织及其相应肿瘤组织中表达的研究[J].南华大学学报(医学版),2006,34(2):176-180. 被引量:6
  • 4Matenia D, Hempp C, Timm T, et al. Microtubule affinity-regula- ting Kinase2 ( MARK2 ) turns on phosphatase and tensin homolog (PTEN) -induced Kinase 1 ( PINK1 ) at Thr-313, a mutation sitein parkinson disease: effects on mitochondrial transport [ J ]. J Biol Chem, 2012(11) :8174 -86.
  • 5Walig6rska-Stachura J, Jankowska A, Wagko R, et al. Survivin- prognostic tumor biomarker in human neoplasms-review [ J ]. Ginekol Pol, 2012,83(7) :537 -40.
  • 6Huang J, Yan J, Zhang J, et al. SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plas- ma membrane[J]. Nat Commun, 2012,19(3) :911.
  • 7Lu H, Gan M, Zhang G, et aL Expression of survivin, caspase-3 and p53 in cervical cancer assessed by tissue mieroarray: correla- tion with clinicopathology and prognosis [ J ]. Eur J Gynaecol On- col, 2010,31(6) :662 -6.
  • 8Yagihashi A, Ohmura T, Asanuma K, et al. Detection of autoanti- bodies to survivin and livin in sera from patients with breast cancer [J]. Clin Chim Acta, 2005,362(1 -2) :125 -30.
  • 9Chen J S, Chen K T, Fan W C, et al. Combined analysis of sur- vivin autoantibody and carcinoembryonic antigen biomarkers for im- proved detection of colorectal cancer [ J ]. Clin Chem Lab Med, 2010,48(5) :719 -25.
  • 10Rebecca S, Jiemin Ma, Zhaohui Zou, et al. Cancer Statistics 2014[J]. CA Cancer J Clin, 2014, 64(1)" 9-29.

共引文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部